Orion Pharma Limited (DSE:ORIONPHARM)

Orion Pharma Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 3, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	7,043	7,090	16,169	18,626	20,592	12,613
Market Cap Growth	-14.25%	-56.15%	-13.19%	-9.54%	63.27%	28.33%
Enterprise Value	34,985	32,164	39,765	42,351	40,514	28,904
Last Close Price	30.10	30.30	67.36	76.63	83.74	50.68
PE Ratio	-	-	50.83	29.06	24.34	13.43
PS Ratio	2.26	1.74	1.52	1.34	2.13	1.16
PB Ratio	0.33	0.33	0.70	0.83	0.99	0.63
P/TBV Ratio	0.35	0.35	0.75	0.89	1.07	0.68
P/FCF Ratio	59.93	21.04	-	-	-	-
P/OCF Ratio	9.82	6.42	10.19	7.47	17.73	4.87
EV/Sales Ratio	11.22	7.88	3.74	3.04	4.19	2.67
EV/EBITDA Ratio	66.96	47.77	26.51	26.91	35.29	11.43
EV/EBIT Ratio	-	575.42	42.80	42.65	60.01	18.79
EV/FCF Ratio	297.69	95.45	-	-	-	-
Debt / Equity Ratio	1.24	1.19	1.03	0.98	0.90	0.84
Debt / EBITDA Ratio	52.00	37.20	15.66	13.74	15.87	6.59
Debt / FCF Ratio	227.59	76.20	-	-	-	-
Net Debt / Equity Ratio	1.23	1.18	1.02	0.97	0.89	0.82
Net Debt / EBITDA Ratio	53.28	37.93	15.70	13.79	16.07	6.48
Net Debt / FCF Ratio	225.46	75.79	-65.08	-15.88	-12.26	-9.72
Asset Turnover	0.06	0.07	0.20	0.28	0.21	0.27
Inventory Turnover	1.30	1.69	5.04	7.12	5.01	6.10
Quick Ratio	1.79	1.79	1.89	1.64	1.59	2.14
Current Ratio	2.06	2.07	2.24	2.01	1.99	2.70
Return on Equity (ROE)	-2.86%	-2.18%	1.55%	3.22%	4.36%	5.73%
Return on Assets (ROA)	-0.07%	0.06%	1.08%	1.23%	0.93%	2.43%
Return on Invested Capital (ROIC)	-0.12%	0.12%	1.35%	1.97%	1.49%	4.24%
Return on Capital Employed (ROCE)	-0.10%	0.10%	2.00%	2.30%	1.70%	4.20%
Earnings Yield	-8.08%	-5.86%	1.97%	3.44%	4.11%	7.45%
FCF Yield	1.67%	4.75%	-2.24%	-7.33%	-7.31%	-13.36%
Dividend Yield	-	-	1.48%	1.31%	1.19%	2.37%
Payout Ratio	-	-	84.84%	23.86%	38.36%	36.22%
Total Shareholder Return	-	-	1.48%	1.31%	1.19%	2.37%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.